Natalizumab Treatment Induces Proinflammatory CD4 T Cells Preferentially in the Integrin β7+ Compartment.
Mélanie Nguyen KyAdrien DuranIris HasantariAgnès BruMathilde DeloireBruno BrochetAurélie RuetNathalie SchmittPublished in: Neurology(R) neuroimmunology & neuroinflammation (2023)
Our study shows that circulating integrin β7+ memory CD4 T cells of patients with relapsing-remitting MS under natalizumab are enriched in proinflammatory cells supporting the hypothesis that integrin β7+ memory CD4 T cells could play a pathogenic role in the disease rebound observed at natalizumab discontinuation.